The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Cannaphyll is a wellness brand that specializes in hemp-infused body-care products, with its hero product being its infused topical cream.
Cannaphyll Infused Topical Cream is the highest-potency hemp-infused topical product sold over the counter in America, with 1000mg of hemp extract in every ounce. Cannaphyll is currently available in the US and UK through Amazon.com, Inc. AMZN, as well as doctors’ offices and retailers nationwide.
Cannaphyll’s patent-pending formula has been scientifically proven to enhance and accelerate cannabinoid bioavailability. Organic ingredients such as elderberry, neroli, and lavender, known for their antioxidant, anti-inflammatory and antibacterial properties, work synergistically with cannabinoids to powerfully and effectively penetrate skin, muscles, nerves, and joints.
Cofounder Kim Clark created Cannaphyll’s original, whole-plant formula in 2011 to provide palliative care for her terminally ill mother and Cannaphyll namesake, Phyllis, who credited cannabis with extending and improving her final years.
Cannaphyll Infused Topical Gel will be released this fall, along with four dozen other products scheduled for release over the next two years. These new releases will include infused body essentials, arousal gels, hair revitalizers, topical antiseptics, and many others.
CEO of Cannaphyll, Jude Bond, will be presenting at the upcoming Benzinga Cannabis Capital Conference to provide an overview of the company and its products, as well as to discuss investment opportunities in Cannaphyll.
To learn more about Cannaphyll, you can sign up for the Benzinga Cannabis Capital Conference by clicking here.
The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.
Meet the biggest cannabis industry players and make deals that will push the industry forward.
Featuring live company presentations, insider panels, and unmatched access to networking, the Benzinga Cannabis Capital Conference is where cannabis executives and entrepreneurs meet.
Join us September 13-14, 2022 at The Palmer House in Chicago, IL.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.